(E)-1-(4-(allyloxy)phenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one | 151135-03-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(4-(allyloxy)phenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one
• 英文别名: 2,4-dimethoxy-4'-(2-propenyloxy)chalcone；2,4dimethoxy4'-prop-2-enyloxychalcone；(E)-3-(2,4-dimethoxyphenyl)-1-(4-prop-2-enoxyphenyl)prop-2-en-1-one
• CAS: 151135-03-4
• 化学式: C₂₀H₂₀O₄
• 分子量: 324.376
• InChiKey: ZMLVULZDLAMOCO-XYOKQWHBSA-N

物化性质

• 沸点：
  497.1±45.0 °C(Predicted)
• 密度：
  1.118±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (E)-1-(4-(allyloxy)phenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one 在 sodium tetrahydroborate 、 copper(l) iodide 、 Dowex 50WX₈-100 (acidic form) 作用下， 以 四氢呋喃 、 乙醇 、 甲苯 为溶剂， 反应 4.25h， 生成 1-[(E)-3-(4-Allyloxy-phenyl)-1-vinyl-allyl]-2,4-dimethoxy-benzene
  参考文献：
  名称：

  Antimalarial and Antiplasmodial Activities of Norneolignans. Syntheses and SAR

  摘要：

  A systematic change of the substituents and side chain of the norneolignan hinokiresinol afforded a 10 fold improvement of the IC50 value toward inhibition of the growth of Plasmodium falciparum. The more potent compounds controlled the parasiterma in mice infected with Plasinodium berghei.

  DOI：

  10.1021/jm0508235
• 作为产物：
  描述：

  对羟基苯乙酮 在 四溴化碳 、 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 22.0h， 生成 (E)-1-(4-(allyloxy)phenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  CBr 4作为卤素键供体催化剂，用于苯甲醛的选择性活化，以合成α，β-不饱和酮

  摘要：

  CBr 4已用作卤素键供体催化剂，用于醛的选择性活化，在强酸敏感基团（例如甲氧基，氰化物，酯，和缩酮用于合成α，β-不饱和酮。CBr 4作为卤素键供体的这种独特能力已经通过紫外可见光谱和红外光谱进行了探索和确立。而且，这种空前的方法能够合成重要的药物分子利可考酮A。

  DOI：

  10.1021/acs.orglett.7b00348

文献信息

• Treatment and prophylaxis of diseases caused by parasites, or bacteria
  申请人：Statens Seruminstitut

  公开号：US05985935A1

  公开（公告）日：1999-11-16

  Aromatic compounds, or prodrugs thereof, which contain an alkylating site and which are capable of alkylating the thiol group in N-acetyl-L-cysteine, in particular bis-aromatic .alpha.,.beta.-unsaturated ketones, are used for the preparation of pharmaceutical compositions or medicated feed, food or drinking water for the treatment or prophylaxis of diseases caused by microorganisms or parasites, in particular protozoa such as Leishmannia, Trypanosoma, Toxoplasma, Plasmodium, Pneumocystis, Babesia and Theileria, intestinal protozoa such as Trichormionas and Ciardia; Coccidia such as Eimeria, Isospora, Cryptosporidium; Cappilaria, Microsporidium, Sarcocystis. Trichlodina, Trichoditella, Dacihylogurus, Pseudodacthylogurus, Acantocephalus, Ichthylophtherius, Botrecephalus; and intracellular bacteria, in particular Mycobacterium, Legionella species, Listeria and Salmonella. Preferred compounds have the formula (II): X.sub.m --Ph--C(O)--CH.dbd.CH--Ph--Y.sub.n, wherein each phenyl group (Ph) may be mono- or polysubstituted; X and Y designate AR.sub.H or AZ, wherein A is O, S, NH or N(C.sub.1-6 alkyl), R.sub.H designates aliphatic hydrocarbyl, and Z is H or a masking group which is decomposed to liberate AH; m is 0, 1 or 2, and n is 0, 1, 2 or 3, whereby, when m is 2, then the two X are the same or different, and when n is 2 or 3, then the two or three Y are the same or different, with the proviso that n and m are not both 0. As examples of such compounds, chalcones, e.g. licochalcone A (obtainable i.a. from batches of Chinese licorice root of Glycyrrhiza species, e.g. G. uralensis or G. inflata) as well as hydroxy, alk(en)yl, and/or alk(en)yloxy analogues thereof are active in vitro and/or in vivo against i.a. L. major and P. falciparum.

  含有烷基化位点的芳香化合物或其前药，能够烷基化N-乙酰-L-半胱氨酸中的硫醇基团，特别是双芳基α，β-不饱和酮，用于制备用于治疗或预防由微生物或寄生虫引起的疾病的药物组合物或药物饲料、食品或饮用水，特别是原虫，如利什曼原虫、锥虫、弓形虫、疟原虫、肺孢子虫、巴贝斯虫和泰勒原虫，肠道原虫，如毛滴虫和贾第虫；球虫，如艾美利亚球虫、异孢子球虫、隐孢子虫；毛细管虫、微小孢子虫、肉囊虫、三鞭毛虫、三鞭毛虫、卵泡头虫、假卵泡头虫、棘头虫、鱼皮虫、蠕虫头虫；以及细胞内细菌，特别是分枝杆菌、军团菌属、李斯特菌和沙门氏菌。优选化合物具有以下公式（II）：X.sub.m --Ph--C(O)--CH.dbd.CH--Ph--Y.sub.n，其中每个苯基（Ph）可以是单取代或多取代；X和Y代表AR.sub.H或AZ，其中A为O、S、NH或N（C.sub.1-6烷基），R.sub.H代表脂肪烃基，Z为H或分解以释放AH的掩蔽基；m为0、1或2，n为0、1、2或3，当m为2时，两个X相同或不同，当n为2或3时，两个或三个Y相同或不同，但n和m不能同时为0。作为这类化合物的例子，香豆素，例如甘草属植物（例如华北甘草或气球甘草）根的批次中可获得的甘草香豆素A，以及其羟基、烯烃基和/或烯烃氧基类似物在体外和/或体内对利什曼原虫和疟原虫具有活性。
• Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
  申请人：Statens Serum Institute

  公开号：US20030065039A1

  公开（公告）日：2003-04-03

  The invention relates to the use of 1,3-bis-aromatic-prop-2-en-1-ones (chalcones), 1,3-bis-aromatic-propan-1-ones (dihydrochalcones), and 1,3-bis-aromatic-prop-2-yn-1-ones for the preparation of pharmaceutical compositions for the treatment or prophylaxis of a number of serious diseases including i) conditions relating to harmful effects of inflammatory cytokines, ii) conditions involving infection by Helicobacter species, iii) conditions involving infection by viruses, iv) neoplastic disorders, and v) conditions caused by microorganisms or parasites. The invention also relates to novel chalcones and dihydrochalcones (especially alkoxy substituted variants) having advantageous substitution patterns with respect to their effect as drug substances, and to methods of preparing them, as well as to pharmaceutical compositions comprising the novel chalcones. Moreover, the present invention relates to a method for the isolation of Leishmania fumarate reductase, QSAR methodologies for selecting potent compounds for the above-mentioned purposes.

  该发明涉及使用1,3-双芳基-丙-2-烯-1-酮（香豆素）、1,3-双芳基-丙酮-1-酮（二氢香豆素）和1,3-双芳基-丙-2-炔-1-酮制备用于治疗或预防多种严重疾病的药物组合物，包括i）与炎症细胞因子有害作用相关的疾病，ii）涉及幽门螺旋杆菌感染的疾病，iii）涉及病毒感染的疾病，iv）肿瘤性疾病，v）由微生物或寄生虫引起的疾病。该发明还涉及新型香豆素和二氢香豆素（特别是烷氧基取代变体），其具有有利的取代模式，对其作为药物物质的效果，以及制备它们的方法，以及包含新型香豆素的药物组合物。此外，本发明涉及一种用于分离利什曼氏弓形虫富马酸还原酶的方法，以及用于选择上述目的的有效化合物的QSAR方法。
• Modifications of the α,β-Double bond in chalcones only Marginally affect the antiprotozoal activities
  作者：Simon Feldbæk Nielsen、Arsalan Kharazmi、S.Brøgger Christensen

  DOI：10.1016/s0968-0896(98)00051-0

  日期：1998.7

  Methods for selective alkylation of chalcones in the alpha- or beta-position and for selective reduction of the alpha,beta-double bond have been developed. The antiparasitic potencies of the alpha,beta-double bond modified chalcones only differ marginally from the potencies of the parent chalcones indicating that the propenone residue only functions as a spacer between the two benzene rings, which are the true pharmacophore. (C) 1998 Elsevier Science Ltd. All rights reserved.
• TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA
  申请人：STATENS SERUMINSTITUT

  公开号：EP0634927A1

  公开（公告）日：1995-01-25
• BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES
  申请人：STATENS SERUMINSTITUT

  公开号：EP0996432A2

  公开（公告）日：2000-05-03